Approximately 25% of men with prostate cancer develop tumor at locations remote from the prostate gland. Prostate cancer mortality is strongly correlated with the development of tumor metastatic disease. Clinical findings indicate existence of significant growth control or metastasis inhibition mechanisms at secondary sites of metastases. Therefore, it is critical to understand the cellular and molecular events that predispose tumor cells to undergo metastasis. ? ? In this research proposal, we plan to use an experimental model of metastatic prostate cancer developed in mice. This model allows us to study the tendency of prostate cancer cells to undergo metastasis. We predict that the tendency for metastasis can be explained by a small subpopulation of cells that have acquired a new genetic defect. We have access to experimental mouse prostate tumor cells that either undergo metastasis or remain localized. We plan to compare the expression patterns of genes in metastatic cells with those of non-metastatic cells. We will then correlate these patterns of gene expression with genomic defects in the cells. The ultimate goal of this project is to identify a subset of genes that may prevent metastasis under normal conditions, but promote metastasis when certain genetic defects occur. Once candidate metastasis-suppressor genes have been identified, their ability to suppress metastasis in a biological assay will be confirmed. ? ? Results from these experiments will provide new information on genes required for the metastasis of prostate cancer. These findings will improve diagnostic and prognostic abilities of physicians caring for these patients as well as leading to new therapeutic targets to prevent metastatic spread of prostate cancer. ? ? The proposed experiments will provide the candidate with new training in cancer biology, and further maturation in bioinformatics. It is expected that his accomplishments during this K01 award period will help the candidate become an independent research in the future. ? ? ? ?

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Scientist Development Award - Research & Training (K01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-RTRB-A (M1))
Program Officer
Eckstein, David J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Vanderbilt University Medical Center
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Qiu, Qingchao; Lu, Pengcheng; Xiang, Yuzhu et al. (2013) A data similarity-based strategy for meta-analysis of transcriptional profiles in cancer. PLoS One 8:e54979
Xiang, Yuzhu; Qiu, Qingchao; Jiang, Ming et al. (2013) SPARCL1 suppresses metastasis in prostate cancer. Mol Oncol 7:1019-30
Li, Xiaohong; Wang, Yongqing; Sharif-Afshar, Ali-Reza et al. (2009) Urothelial transdifferentiation to prostate epithelia is mediated by paracrine TGF-beta signaling. Differentiation 77:95-102
Wu, Jun; Qiu, Qingchao; Xie, Lu et al. (2009) Web-based interrogation of gene expression signatures using EXALT. BMC Bioinformatics 10:420
Wilting, Saskia M; de Wilde, Jillian; Meijer, Chris J L M et al. (2008) Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer. Genes Chromosomes Cancer 47:890-905
Yi, Yajun; Li, Chun; Miller, Clay et al. (2007) Strategy for encoding and comparison of gene expression signatures. Genome Biol 8:R133